Key Takeaways
- Rocket Lab finalized its at-the-market equity offering by selling approximately 6.7 million shares, generating around $474 million in gross capital.
- The aerospace firm simultaneously initiated collared forward agreements covering roughly 7.5 million shares, with expected proceeds ranging from $474 million to $642 million.
- Capital raised will support expansion initiatives, possible acquisitions, and operational funding needs.
- Citizens analyst Trevor Walsh raised his rating on RKLB to Buy from Hold, maintaining an $85 price objective.
- Wall Street’s consensus price target stands at $86.77, suggesting approximately 25.6% potential appreciation.
Rocket Lab wrapped up its $1 billion at-the-market equity offering initiative this Wednesday, securing approximately $474 million in gross capital. Shares responded with a roughly 5% climb.
The aerospace company executed sales of about 6.7 million shares via at-the-market mechanisms. Simultaneously, it established collared forward agreements encompassing approximately 7.5 million shares.
These forward arrangements anticipate minimum proceeds near $474 million, with a ceiling around $642 million. The contracts mature in April 2028, though the company retains flexibility for earlier settlement.
The offering initiative originated on March 17, 2026, when Rocket Lab submitted a prospectus supplement authorizing stock sales up to $1 billion. Wednesday’s announcement marked the program’s conclusion.
Rocket Lab indicated the net capital will finance expansion efforts, including prospective acquisitions, alongside general corporate needs and operational funding. The company hasn’t disclosed specific acquisition prospects.
The stock’s advancement occurred during a broadly favorable session for equity markets, creating supportive conditions.
Wall Street Upgrades Drive Positive Sentiment
Earlier this week, Trevor Walsh from Citizens elevated RKLB to Buy from Hold. He maintained his $85 valuation target, representing approximately 25% appreciation potential from prevailing prices.
Walsh identified current valuation levels as an attractive entry opportunity. He emphasized Rocket Lab’s expansion into defense contracts and space services as drivers for improved profitability and revenue consistency.
Walsh referenced the expected SpaceX public offering — potentially commanding a $2 trillion valuation — as a trigger that might draw increased institutional capital toward space industry stocks.
Sujeeva De Silva at Roth MKM maintained a Buy recommendation with a $90 valuation objective. De Silva underscored the company’s expanding contract pipeline and its strategic move into satellite component manufacturing.
De Silva characterized Rocket Lab as “successfully diversifying into Space Systems,” extending beyond traditional launch services. He views the growing backlog as confirmation of robust expansion prospects.
According to TipRanks data, RKLB carries a Moderate Buy consensus. This reflects 10 Buy recommendations and five Hold ratings issued during the past three months.
The consensus valuation target among these analysts reaches $86.77, implying roughly 25.6% appreciation potential from present trading levels.
Neutron Rocket Development Draws Strategic Focus
Beyond the capital raise, Rocket Lab’s Neutron launch vehicle continues generating strategic interest. The 43-meter partially reusable platform targets satellite deployment and cargo transport missions.
Critical components — including the “Hungry Hippo” payload fairing and primary thrust assembly — are prepared for final integration. Initial launch operations are projected for late 2026 or early 2027.
Gregory Pendy from Clear Street observed that Neutron could capture a broader market segment than the Electron rocket while delivering enhanced revenue per mission. This positions it as a critical expansion catalyst.
Rocket Lab’s shares have experienced volatility throughout 2026, with modest net performance year-to-date. The consensus analyst valuation presently stands at $86.77.
